A Study in the US Based on Pharmacy and Medical Claims That Compares How Well Stiolto® and Trelegy® Work in People With Chronic Obstructive Pulmonary Disease (COPD)

NCT05169424 · clinicaltrials.gov ↗

COMPLETED

Status

9117

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DEVICE: Trelegy Ellipta
DEVICE: Stiolto Respimat
DRUG: Tiotropium + Olodaterol (5/5 mcg)
DRUG: Fluticasone Furoate + Umeclidinium + Vilanterol (100/62.5/25 mcg)

Sponsor

Boehringer Ingelheim